About

BU ADC
The Boston University Alzheimer’s Disease Center (BU ADC) was established in 1996 as one of 29 centers in the US funded by the National Institutes of Health to advance research on Alzheimer’s disease and related conditions. The BU ADC, through its CTE Center, also fosters and supports high-impact, innovative research on Chronic Traumatic Encephalopathy and other long-term consequences of repetitive brain trauma in athletes and military personnel, including studies funded by the National Institutes of Health, the Department of Veterans Affairs, the Sports Legacy Institute, and the Department of Defense.

CTE Center
The CTE Center is part of the Boston University Alzheimer’s Disease Center (BU ADC), established in 1996 as one of 29 centers in the US funded by the National Institutes of Health to advance research on Alzheimer’s disease and related conditions. In collaboration with other NIH-funded ADC’s and the non-profit Sports Legacy Institute, CTE Center conducts high-impact, innovative research on Chronic Traumatic Encephalopathy and other long-term consequences of repetitive brain trauma in athletes and military personnel. The mission of the CTE Center is to conduct state-of-the-art research on CTE, including its neuropathology and pathogenesis, clinical presentation, genetics and other risk factors, biomarkers, methods of detection during life, and methods of prevention and treatment.